Drug recall · March 9, 2022
Olanzapine Tablets recall
Why: cGmp Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Olanzapine Tablets, USP 10 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA , Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, HImachal Pradesh, India, NDC 33342-070-07.
- Lots / codes
Lot #: BOB42029A, BOB4202B, Exp. Date 09/2022
- Quantity
- 3672 bottles
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- Nationwide within the United States
- Initiated
- February 16, 2022 · Voluntary: Firm initiated
- Classified
- February 28, 2022
- Reported
- March 9, 2022
- Ended
- October 16, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olanzapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.